EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress
NCT: NCT07027657 · COMPLETED
Brief Summary
The goal of this clinical trial is to evaluate whether the treatment with BTL-699-2 device is able to improve sleep quality and reduce stress in adults above the age of 22 years. The main questions it aims to answer are: Does the treatment with BTL-699-2 device improve sleep quality? Does the treatment with BTL-699-2 device reduce stress? Participants will be asked to: * Undergo six treatments * Complete the Pittsburgh Sleep Quality Index * Complete the Perceived Stress Scale Questionnaire * Complete the Sleep and Stress Assessment Questionnaire * Complete the Therapy Comfort and Subject Satisfaction Questionnaire
Frequently Asked Questions
What is EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress?
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress is a clinical trial registered under NCT07027657. Current status: COMPLETED.
What is the status of NCT07027657?
The current status of NCT07027657 (EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress) is: COMPLETED.
When did EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress start?
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress started on 2025-05-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.